 |
|
|
| |
Frailty Is Associated With Higher MACE Incidence but Does Not Appear to Modify Pitavastatin Effects
|
| |
| |
CROI 2025 SF March 9-12
Kristine M. Erlandson, Ariela R. Orkaby, Triin Umbleja, Heather Ribaudo, Todd Brown, Kathleen V. Fitch, Carlos Malvestutto, Karen T. Tashima, Marcus V. G. Lacerda, Sonya L. Heath, Alan Landay, George A. Kuchel, Pamela Douglas, Steven Grinspoon, for the REPRIEVE Study Team
|
| |
|
|
|
|
|
